Fain Eric S
Known title: DirectorCIK: 0001402222
Fain Eric S's purchase track record
Fain Eric S has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/14/2026 | OBIO | $83K | +8.3% | pending | — |
| 8/25/2025 | OBIO | $15K | +86.2% | +55.0% | +6.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OBIO | ▼ Sell | Tax Withholding | 5,145 | $23K | 8/12/2026 | View on chart |
| OBIO | ▼ Sell | Tax Withholding | 4,261 | $0 | 6/24/2026 | View on chart |
| OBIO | ▲ Buy | Grant | 17,327 | $0 | 6/23/2026 | View on chart |
| OBIO | ▲ Buy | Open Market | 20,000 | $83K | 5/14/2026 | View on chart |
| OBIO | ▲ Buy | Open Market | 5,760 | $15K | 8/25/2025 | View on chart |
| OBIO | ▲ Buy | Grant | 7,500 | $0 | 8/7/2025 | View on chart |
| OBIO | ▲ Buy | Grant | 7,500 | $0 | 8/7/2025 | View on chart |
| OBIO | ▼ Sell | Open Market | 2,683 | $8K | 6/26/2025 | View on chart |
| OBIO | ▲ Buy | Grant | 12,422 | $0 | 6/24/2025 | View on chart |
| OBIO | ▼ Sell | Open Market | 1,800 | $10K | 9/10/2024 | View on chart |
| OBIO | ▼ Sell | Open Market | 1,800 | $10K | 9/9/2024 | View on chart |
| OBIO | ▼ Sell | Open Market | 2,000 | $11K | 9/6/2024 | View on chart |
| OBIO | ▲ Buy | Grant | 5,376 | $0 | 6/20/2024 | View on chart |
| OBIO | ▲ Buy | Grant | 11,667 | $0 | 7/20/2023 | View on chart |
| OBIO | ▲ Buy | Option Exercise | 2,906 | $3K | 5/10/2023 | View on chart |
| OBIO | ▲ Buy | Option Exercise | 4,796 | — | 4/12/2023 | View on chart |
| OBIO | ▲ Buy | Grant | 22,065 | — | 1/26/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
OBIO Shares Rise 5.2% Amid Positive Momentum
Orchestra BioMed Holdings (OBIO) shares recently increased by 5.2%, a move that some observers see as a sign of strengthening momentum. The stock currently trades within its 52-week range of $2.20 to $6.48. Analysts maintain an average price target of $12.14, suggesting a significant gap between the current market price and professional estimates.
OBIO Shares Rise 5.2% Amid Positive Momentum. Orchestra BioMed Holdings (OBIO) shares recently increased by 5.2%, a move that some observers see as a sign of strengthening momentum. The stock currently trades within its 52-week range of $2.20 to $6.48. Analysts maintain an average price target of $12.14, suggesting a significant gap between the current market price and professional estimates.